Abbott Laboratories

Thêm thông tin về Abbott Laboratories Công ty

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.

Thông tin công ty

Mã công tyABT

Tên công tyAbbott Laboratories

Ngày IPOMar 01, 1937

Được thành lập vào1900

CEOMr. Robert B. Ford

Số lượng nhân viên114000

Loại chứng khoánOrdinary Share

Kết thúc năm tài chínhMar 01

Địa chỉ100 Abbott Park Road

Thành phốABBOTT PARK

Sàn giao dịch chứng khoánNYSE Consolidated

Quốc giaUnited States of America

Mã bưu điện60064-3500

Điện thoại12246676100

Trang webhttps://www.abbott.com

Mã công tyABT

Ngày IPOMar 01, 1937

Được thành lập vào1900

Lãnh đạo công ty

Tên

Tên/Chức vụ

Chức vụ

Tỷ lệ sở hữu cổ phần

Thay đổi

Mr. Daniel J. Starks

Independent Director

6.73M

+0.02%

Mr. Hubert L. Allen

Executive Vice President, General Counsel, Secretary

191.90K

+3.84%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

133.77K

+6.42%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-0.82%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.88K

-1.63%

Mr. Philip P. Boudreau

Chief Financial Officer, Executive Vice President - Finance

56.91K

+44.72%

Dr. Robert J. Alpern, M.D.

Independent Director

40.80K

+4.17%

Ms. Nancy Mckinstry

Lead Independent Director

38.72K

+4.41%

Ms. Sally E. Blount, Ph.D.

Independent Director

36.66K

+4.67%

Xem thêm

Tên

Tên/Chức vụ

Chức vụ

Tỷ lệ sở hữu cổ phần

Thay đổi

Mr. Daniel J. Starks

Independent Director

6.73M

+0.02%

Mr. Hubert L. Allen

Executive Vice President, General Counsel, Secretary

191.90K

+3.84%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

133.77K

+6.42%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-0.82%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.88K

-1.63%

Phân tích doanh thu

Tiền tệ: USDThời gian cập nhật: CN, 6 Th04

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Theo Doanh nghiệpUSD

Tên

Doanh thu

Tỷ trọng

Diabetes Care

6.80B

16.22%

Core Laboratory

5.24B

12.48%

Adult Nutritionals

4.39B

10.46%

Pediatric Nutritionals

4.02B

9.59%

Key Emerging Markets

3.86B

9.20%

Other

17.64B

42.05%

Theo Khu vựcUSD

Tên

Doanh thu

Tỷ trọng

United States

16.32B

38.91%

All other Countries

14.85B

35.39%

Germany

2.54B

6.05%

China

2.11B

5.04%

India

1.82B

4.33%

Other

4.31B

10.28%

Theo Doanh nghiệp

Theo Khu vực

Theo Doanh nghiệpUSD

Tên

Doanh thu

Tỷ trọng

Diabetes Care

6.80B

16.22%

Core Laboratory

5.24B

12.48%

Adult Nutritionals

4.39B

10.46%

Pediatric Nutritionals

4.02B

9.59%

Key Emerging Markets

3.86B

9.20%

Other

17.64B

42.05%

Cổ đông

Thời gian cập nhật: CN, 9 Th02

Cổ đông Thống kê

Loại

Cổ đông Thống kê

Cổ đông

Tỷ trọng

The Vanguard Group, Inc.

9.68%

BlackRock Institutional Trust Company, N.A.

5.02%

State Street Global Advisors (US)

4.45%

Capital International Investors

3.92%

Capital Research Global Investors

3.12%

Other

73.81%

Cổ đông Thống kê

Cổ đông

Tỷ trọng

The Vanguard Group, Inc.

9.68%

BlackRock Institutional Trust Company, N.A.

5.02%

State Street Global Advisors (US)

4.45%

Capital International Investors

3.92%

Capital Research Global Investors

3.12%

Other

73.81%

Loại

Cổ đông

Tỷ trọng

Investment Advisor

35.63%

Investment Advisor/Hedge Fund

32.73%

Research Firm

3.15%

Pension Fund

2.28%

Bank and Trust

2.13%

Sovereign Wealth Fund

1.31%

Insurance Company

0.99%

Hedge Fund

0.89%

Individual Investor

0.48%

Other

20.41%

Cổ phần của tổ chức

Thời gian cập nhật: CN, 19 Th01

Chu kỳ Báo cáo

Số lượng tổ chức

Cổ phiếu nắm giữ

Tỷ trọng

Thay đổi

2025Q1

4527

1.39B

80.29%

+21.54M

2024Q4

4535

1.39B

80.22%

+15.89M

2024Q3

4391

1.36B

78.29%

-11.85M

2024Q2

4400

1.36B

78.24%

-7.03M

2024Q1

4402

1.35B

77.67%

-9.71M

2023Q4

4429

1.35B

77.56%

-11.05M

2023Q3

4298

1.34B

77.39%

-25.33M

2023Q2

4297

1.35B

77.60%

-13.55M

2023Q1

4281

1.35B

77.46%

-8.61M

2022Q4

4258

1.34B

76.84%

-15.37M

Xem thêm

Hoạt động của Cổ đông

Tên

Cổ phiếu nắm giữ

Tỷ trọng

Thay đổi

Thay đổi %

Ngày

The Vanguard Group, Inc.

167.89M

9.68%

+762.54K

+0.46%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

87.07M

5.02%

+811.85K

+0.94%

Dec 31, 2024

State Street Global Advisors (US)

77.17M

4.45%

+447.25K

+0.58%

Dec 31, 2024

Capital International Investors

67.97M

3.92%

+2.23M

+3.39%

Dec 31, 2024

Capital Research Global Investors

54.10M

3.12%

+795.07K

+1.49%

Dec 31, 2024

Geode Capital Management, L.L.C.

35.67M

2.06%

+765.64K

+2.19%

Dec 31, 2024

Wellington Management Company, LLP

26.39M

1.52%

+581.33K

+2.25%

Dec 31, 2024

JP Morgan Asset Management

25.13M

1.45%

+5.11M

+25.51%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

20.98M

1.21%

+626.72K

+3.08%

Dec 31, 2024

Wells Fargo Advisors

15.25M

0.88%

-105.40K

-0.69%

Dec 31, 2024

Xem thêm

ETF liên quan

Thời gian cập nhật: T7, 5 Th04

Tên

Tỷ trọng

iShares U.S. Medical Devices ETF

17.41%

Invesco Pharmaceuticals ETF

5.78%

Goldman Sachs Future Health Care Equity ETF

5.19%

NYLI Healthy Hearts ETF

4.78%

Polen Capital Global Growth ETF

4.77%

AdvisorShares Focused Equity ETF

4.63%

Proshares Ultra Health Care

4.32%

Health Care Select Sector SPDR Fund

4.24%

iShares U.S. Healthcare ETF

4.15%

Fidelity MSCI Health Care Index ETF

3.85%

Xem thêm

iShares U.S. Medical Devices ETF

Tỷ trọng17.41%

Invesco Pharmaceuticals ETF

Tỷ trọng5.78%

Goldman Sachs Future Health Care Equity ETF

Tỷ trọng5.19%

NYLI Healthy Hearts ETF

Tỷ trọng4.78%

Polen Capital Global Growth ETF

Tỷ trọng4.77%

AdvisorShares Focused Equity ETF

Tỷ trọng4.63%

Proshares Ultra Health Care

Tỷ trọng4.32%

Health Care Select Sector SPDR Fund

Tỷ trọng4.24%

iShares U.S. Healthcare ETF

Tỷ trọng4.15%

Fidelity MSCI Health Care Index ETF

Tỷ trọng3.85%

Cổ tức

Tổng cộng 16.46B USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Ngày

Cổ tức

Ngày ghi sổ

Ngày thanh toán

Ngày không hưởng cổ tức

Dec 13, 2024

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option

Jan 15, 2025

Feb 14, 2025

Jan 15, 2025

Sep 19, 2024

ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024

Oct 15, 2024

Nov 15, 2024

Oct 15, 2024

Jun 15, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option

Jul 15, 2024

Aug 15, 2024

Jul 15, 2024

Feb 16, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024

Apr 15, 2024

May 15, 2024

Apr 12, 2024

Dec 15, 2023

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option

Jan 12, 2024

Feb 15, 2024

Jan 11, 2024

Sep 21, 2023

ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option

Oct 13, 2023

Nov 15, 2023

Oct 12, 2023

Jun 09, 2023

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option

Jul 14, 2023

Aug 15, 2023

Jul 13, 2023

Feb 17, 2023

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option

Apr 14, 2023

May 15, 2023

Apr 13, 2023

Dec 09, 2022

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option

Jan 13, 2023

Feb 15, 2023

Jan 12, 2023

Sep 15, 2022

ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option

Oct 14, 2022

Nov 15, 2022

Oct 13, 2022

Xem thêm

Chia tách cổ phiếu

Ngày

Loại

Tỷ lệ

Không có dữ liệu

Ngày

Loại

Tỷ lệ

Không có dữ liệu

130.620USD

Abbott Laboratories

130.620

Tổng quan

Công ty